When Medical Conditions Masquerade as Behavioral Problems: A Guide for Behavior Analysts Working with ASD

Overview & Clinical Significance

A seven-year-old with autism who has been engaging in escalating self-injurious behavior for the past three weeks is referred for a functional behavior assessment. The behavior analyst conducts the assessment and identifies automatic reinforcement as the maintaining function. An intervention plan is developed targeting the SIB with competing stimuli and differential reinforcement. Six weeks later, the behavior has not decreased. What was missed?

In a significant number of cases like this, the answer is a medical condition. Chris McGinnis's presentation addresses one of the most consequential blind spots in behavior-analytic practice: the failure to recognize when behavioral presentations are caused or exacerbated by underlying medical or biological conditions. The research cited in this course suggests that as many as one in five adults seeking mental health services have an undiagnosed medical condition directly causing their symptoms, and three in four have a condition making symptoms worse. For individuals with autism spectrum disorder, particularly those who are nonverbal, the prevalence is likely higher.

This is not a peripheral concern. It sits at the center of competent practice. When a behavior analyst develops an intervention for behavior that is driven by pain, gastrointestinal distress, seizure activity, sleep disorders, or other medical issues, the intervention is addressing the wrong variable. The behavior will not respond to behavioral contingencies because it is not primarily maintained by behavioral contingencies. The client suffers twice: once from the undiagnosed medical condition and once from an intervention that cannot work because it targets the wrong cause.

The clinical significance of this problem is compounded by the communication challenges inherent in autism spectrum disorder. Individuals who can report that their stomach hurts, that they have a headache, or that they feel dizzy are more likely to be evaluated medically. Those who cannot verbalize their experience, which includes up to half of children on the autism spectrum, communicate their distress through the behavioral channel. And when that behavioral communication is interpreted purely through a behavioral lens, the medical condition goes undetected.

This course equips behavior analysts with the knowledge to recognize when a behavioral presentation may have a medical component, the vocabulary to communicate concerns to medical professionals, and the clinical judgment to initiate appropriate referrals. These skills fill a critical gap in behavior-analytic training that has real consequences for client welfare.

Background & Context

The concept of medical masquerade originates from diagnostic medicine, where it refers to medical conditions that present with symptoms typically associated with psychiatric or behavioral disorders. Classic examples include thyroid dysfunction presenting as depression or anxiety, urinary tract infections presenting as confusion or agitation in elderly patients, and autoimmune encephalitis presenting as psychosis. In each case, the behavioral or psychological presentation obscures the underlying medical cause, leading to misdiagnosis and ineffective treatment.

For individuals with ASD, the medical masquerade problem is amplified by several factors. First, communication barriers mean that many individuals cannot report physical symptoms verbally. Second, diagnostic overshadowing occurs when clinicians attribute all behavioral changes to the autism diagnosis rather than investigating medical causes. Third, individuals with ASD may express pain and discomfort through atypical behavioral patterns that do not match the presentation expected by medical professionals. A child who increases self-injurious behavior when experiencing ear pain may not display the crying, ear-touching, or verbalizations that typically prompt medical investigation.

The medical conditions most commonly involved in behavioral masquerade among individuals with ASD include gastrointestinal disorders, which have a significantly elevated prevalence in this population. Constipation, gastroesophageal reflux, food allergies and intolerances, and inflammatory bowel conditions can all produce pain and discomfort that manifests as increased aggression, self-injury, sleep disruption, or decreased compliance with demands. Seizure disorders, present in an estimated 20 to 30 percent of individuals with ASD, can cause behavioral changes that precede, accompany, or follow seizure activity. Sleep disorders, dental pain, vision and hearing problems, and allergic conditions round out the most common culprits.

The behavior-analytic training pipeline historically has not emphasized medical screening as a core competency. Coursework in functional assessment focuses on identifying behavioral functions, reinforcement contingencies, and environmental variables. While some texts mention the importance of ruling out medical causes before conducting a functional analysis, the practical skills needed to do this effectively are rarely taught. Practitioners are told to rule out medical factors but not shown how to do it.

Chris McGinnis's emphasis on interdisciplinary collaboration reflects the practical reality that behavior analysts cannot diagnose medical conditions. What they can do, however, is recognize patterns that suggest a medical component, communicate those observations to medical professionals in a way that facilitates appropriate evaluation, and adjust their behavioral assessment and intervention accordingly. This requires a working knowledge of the most common medical masqueraders and the behavioral patterns they produce.

Clinical Implications

The clinical implications of medical masquerade affect every stage of the behavior-analytic service delivery process, beginning with intake and continuing through ongoing treatment. At intake, behavior analysts should implement systematic screening for medical and biological conditions that are known to co-occur with ASD at elevated rates. This screening does not require medical expertise; it requires asking the right questions and knowing what answers should trigger a referral.

The screening should cover recent changes in the client's medical status, including new medications or dosage changes, recent illnesses, and any medical evaluations or diagnoses in the past year. It should also cover chronic conditions that are often present but underdiagnosed in individuals with ASD: gastrointestinal symptoms such as constipation, diarrhea, or feeding difficulties; sleep patterns including difficulty falling asleep, frequent waking, or changes in sleep duration; dental history and last dental examination; vision and hearing screening history; and seizure history or concerns.

When behavioral changes occur suddenly or do not follow expected environmental patterns, the behavior analyst should consider medical etiology before developing a behavioral intervention. A sudden increase in aggression with no corresponding environmental change is a red flag. A new pattern of self-injury that targets a specific body area is a red flag. Behavioral changes that correlate with meal times, time of day, or physical activities may suggest a medical component. Cyclical behavioral patterns that do not correspond to environmental cycles may indicate a medical condition with its own temporal pattern.

Functional assessment methodology should incorporate medical hypothesis testing. If a functional analysis yields unclear or inconsistent results, the possibility of a medical maintaining variable should be explicitly considered. Behavior that appears to be maintained by automatic reinforcement deserves particular scrutiny, as this is the functional category most likely to mask a medical condition. Pain-related behavior is often classified as automatically reinforced because it occurs across conditions and does not appear to be maintained by social consequences.

The referral process itself requires clinical skill. Medical professionals may not recognize the significance of behavioral changes reported by a behavior analyst, particularly if they are unfamiliar with ABA or with the communication challenges of individuals with ASD. Effective referral communications should describe the behavioral changes in concrete, observable terms; note the onset, frequency, and duration of the changes; describe what environmental variables have been ruled out through assessment; and specifically request evaluation for conditions that are consistent with the behavioral presentation.

Once a medical referral has been made, the behavior analyst's role does not end. They should continue collecting data to monitor whether behavioral changes correlate with medical treatment. If a client's aggression decreases following treatment for constipation, this provides valuable information about the maintaining variables and should inform future clinical decision-making. Conversely, if medical treatment does not produce behavioral change, this may indicate that the medical condition was not the primary driver, or that the behavioral pattern has acquired additional maintaining contingencies over time.

Ethical Considerations

The ethical obligations surrounding medical masquerade are among the most serious that behavior analysts face, because the consequences of failing to identify a medical condition can include prolonged suffering, unnecessary restrictive interventions, and delayed medical treatment that may worsen the underlying condition.

Code 2.01 of the Ethics Code requires behavior analysts to provide effective treatment. If behavior is being maintained by a medical condition, then behavioral intervention alone cannot constitute effective treatment because it does not address the actual cause. Continuing behavioral intervention without investigating a possible medical component, particularly when the behavioral data suggest an atypical pattern, falls short of this ethical standard.

Code 2.13 addresses the selection of behavior-change procedures and requires behavior analysts to consider the current best available evidence. The evidence on medical comorbidities in ASD is substantial and well-established. A behavior analyst who does not consider medical factors when assessing sudden behavioral changes or treatment-resistant behavioral patterns is not acting in accordance with current evidence.

Code 2.10 addresses collaboration with other professionals. When a behavior analyst suspects a medical condition, the ethical obligation is to communicate this concern to the appropriate medical provider and to the client's caregivers. Failing to make a referral because it falls outside the behavior analyst's scope of practice does not absolve the responsibility to identify the need for the referral. The scope of practice does not include diagnosing medical conditions, but it absolutely includes recognizing when medical evaluation is warranted.

Code 3.01 addresses behavior-analytic assessment and requires that assessments be conducted in a manner consistent with the current research literature. The research literature clearly documents the elevated prevalence of medical conditions in individuals with ASD and the frequency with which these conditions present as behavioral changes. An assessment that does not screen for medical variables is incomplete by current standards.

There is also an ethical dimension related to the use of restrictive procedures. If a behavior analyst recommends or implements a restrictive intervention for behavior that is caused by a medical condition, the intervention is not only ineffective but also subjects the individual to unnecessary restriction. A child who is engaging in SIB because they are in pain does not need an extinction procedure; they need medical evaluation and treatment. The ethical obligation to use least restrictive procedures is violated when the analysis leading to the procedure selection is itself incomplete.

The ethical implications extend to the organizational level. Agencies and practices have an obligation to ensure that their clinicians are trained to recognize medical masquerade and that their intake and assessment processes include appropriate medical screening. Organizations that do not provide this training create conditions in which ethical violations are more likely to occur, and the organizational culture bears responsibility for systemic failures.

Assessment & Decision-Making

A systematic approach to screening for medical masquerade should be embedded into the standard assessment process. At intake, the behavior analyst should complete a medical and biological screening questionnaire that covers the conditions most commonly associated with behavioral changes in individuals with ASD. This questionnaire should be revisited at regular intervals, not just at intake, because medical conditions can develop at any point during the course of treatment.

The screening should include questions about gastrointestinal function (frequency and consistency of bowel movements, signs of reflux, food refusal or selectivity changes), sleep (onset latency, night waking, total sleep duration, snoring or breathing irregularities), pain indicators (guarding of body areas, changes in mobility or posture, facial grimacing), seizure indicators (staring episodes, sudden behavioral arrests, unusual motor movements, post-ictal confusion or sleepiness), and sensory changes (responses to visual or auditory stimuli that have changed recently).

When behavioral data suggest a possible medical component, the decision-making process should follow a structured protocol. First, document the behavioral pattern that raises concern, including onset, frequency, duration, topography, and any temporal correlations with meals, medication, sleep, or other biological variables. Second, review whether environmental changes could account for the pattern. Third, if environmental explanations are insufficient, consult with the caregiver about any medical concerns they may have, as caregivers often notice changes that have not yet been reported to providers.

The decision to refer should be based on the pattern of evidence rather than a single observation. However, when a behavioral change is sudden, severe, or involves a new topography of self-injury, referral should be prompt rather than delayed pending additional data collection. The cost of an unnecessary medical evaluation is far less than the cost of delayed treatment for a medical condition.

Collaboration with medical professionals requires the behavior analyst to translate behavioral observations into language that is meaningful in a medical context. Rather than reporting that a client's aggression has increased by 30 percent, describe the specific behaviors observed, the body areas targeted during self-injury, the correlation with activities such as eating or lying down, and any changes in the client's appearance or physical presentation. This detailed behavioral description gives the medical professional the information they need to generate diagnostic hypotheses.

After a medical referral and evaluation, the behavior analyst should integrate the medical findings into their assessment. If a medical condition is identified and treated, continue collecting behavioral data to assess whether the treatment resolves the behavioral concern. If the behavioral pattern persists after medical treatment, this suggests that additional maintaining variables are present, and a standard behavioral assessment is then appropriate. This sequential assessment approach ensures that medical variables are addressed before behavioral variables are manipulated.

Maintaining a log of medical screening and referral activity for each client provides documentation that the behavior analyst fulfilled their professional obligations and demonstrates a pattern of thorough assessment practice.

What This Means for Your Practice

Add a medical screening component to your intake process if you do not already have one. This does not need to be elaborate. A structured questionnaire covering gastrointestinal health, sleep, seizure history, pain indicators, dental status, and sensory functioning provides a baseline that you can reference when behavioral changes occur later in treatment.

Develop a decision rule for your practice: when a client presents with sudden behavioral changes that cannot be accounted for by environmental variables, initiate a medical screening conversation with the caregiver before developing a new behavioral intervention plan. This simple protocol can prevent months of ineffective behavioral treatment.

Build relationships with the medical professionals who serve your clients. When you eventually need to make a referral, having an established relationship with a pediatrician, neurologist, or gastroenterologist who understands ABA and respects your observations makes the referral process far more effective. Offer to share behavioral data with medical providers, as this data can be diagnostically useful in ways that medical professionals may not initially recognize.

Train your staff to recognize the behavioral red flags that suggest medical involvement. Technicians who spend the most time with clients are often the first to notice changes, but they may not know what to do with that observation. Create a reporting structure that ensures these observations reach the supervising BCBA promptly.

When you do make a referral, follow up. Track whether the medical evaluation occurred, what the findings were, and whether medical treatment produced behavioral changes. This follow-through closes the loop and ensures that the referral was not just a procedural step but an integrated part of the clinical process.